JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201158200 on February 28, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16682-16688, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16682    most recent
M201158200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorenbos, R.
Right arrow Articles by van Dijl, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorenbos, R.
Right arrow Articles by van Dijl, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thiol-Disulfide Oxidoreductases Are Essential for the Production of the Lantibiotic Sublancin 168*

Ronald DorenbosDagger , Torsten Stein§, Jorrit KabelDagger , Claude Bruand, Albert Bolhuis||**, Sierd Bron||, Wim J. QuaxDagger DaggerDagger, and Jan Maarten van DijlDagger

From the Dagger  Department of Pharmaceutical Biology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands, the § Institut für Mikrobiologie, J. W. Goethe Universität, Marie-Curie-Str. 9, 60439 Frankfurt am Main, Germany,  Génétique Microbienne, Institut National de la Recherche Agronomique-Domaine de Vilvert, 78352 Jouy en Josas cedex, France, and the || Department of Genetics, University of Groningen, Kerklaan 30, PO Box 14, 9750 AA Haren, the Netherlands

Received for publication, February 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Thiol-disulfide oxidoreductases are required for disulfide bond formation in proteins that are exported from the cytoplasm. Four enzymes of this type, termed BdbA, BdbB, BdbC, and BdbD, have been identified in the Gram-positive eubacterium Bacillus subtilis. BdbC and BdbD have been shown to be critical for the folding of a protein required for DNA uptake during natural competence. In contrast, no function has been assigned so far to the BdbA and BdbB proteins. The bdbA and bdbB genes are located in one operon that also contains the genes specifying the lantibiotic sublancin 168 and the ATP-binding cassette transporter SunT. Interestingly sublancin 168 contains two disulfide bonds. The present studies demonstrate that SunT and BdbB, but not BdbA, are required for the production of active sublancin 168. In addition, the BdbB paralogue BdbC is at least partly able to replace BdbB in sublancin 168 production. These observations show the unprecedented involvement of thiol-disulfide oxidoreductases in the synthesis of a peptide antibiotic. Notably BdbB cannot complement BdbC in competence development, showing that these two closely related thiol-disulfide oxidoreductases have different, but partly overlapping, substrate specificities.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacillus subtilis is a Gram-positive soil bacterium that is particularly well known for its high protein secretion potential (1, 2). A small group of secreted Bacillus proteins is formed by lantibiotics, small post-translationally modified peptides that exhibit antimicrobial activity (3-5). In general, lantibiotics are characterized by the presence of the unusual amino acids 2,3-didehydroalanine and/or 2,3-didehydrobutyrine, which are formed by dehydration of serine and threonine residues, respectively (6). With neighboring cysteine residues they can form a lanthionine (2,3-didehydroalanine) or 3-methyllanthionine bridge (2,3-didehydrobutyrine). To date two lantibiotics of B. subtilis have been characterized in detail. These are subtilin from B. subtilis ATCC 6633 (7, 8) and sublancin 168 from B. subtilis 168 (9). In addition, two lantibiotic-like peptides originating from the ericin gene cluster of B. subtilis A1/3 were recently described (10). Notably sublancin 168 displays the extraordinary characteristic of having two disulfide bonds in addition to a beta -methyllanthionine bridge (Fig. 1).

Sublancin 168, specified by sunA, was identified as a type AII lantibiotic by Paik et al. (9) in 1998. Presumably it acts by forming pores in the cytoplasmic membrane of a sensitive organism (11). Type AII lantibiotics are characterized by a "double glycine" GG, GA, or GS motif in their leader sequence, GS in sublancin 168, which is preceded by conserved EL or EV and EL or EM sequences. Cleavage occurs immediately behind the double glycine motif during transport by a dual-function transporter that also has leader peptidase activity. The leader is thought to prevent the lantibiotic from becoming active before translocation (12, 13). The sunT gene, which is located directly downstream of sunA, encodes a protein possessing features of a dual-function ATP-binding cassette transporter with a proteolytic domain and an ATP-binding cassette. These domains are common among lantibiotic transporters (3).

Interestingly the sublancin 168 operon appears to include the bdbA and bdbB genes (bdb for Bacillus disulfide bond) downstream of sunT (Fig. 2). The corresponding BdbA and BdbB proteins were previously identified by Bolhuis et al. (14) and have been implicated in thiol-disulfide redox reactions. BdbA shows sequence similarity to the thiol-disulfide oxidoreductase Bdb of Bacillus brevis (15, 16), whereas BdbB shows significant sequence similarity to DsbB of Escherichia coli (15 ,17). BdbB was shown to be involved in the folding of PhoA of E. coli upon the expression of this secretory protein in B. subtilis. As PhoA contains two disulfide bonds, this indicates that BdbB is involved in disulfide bond formation. However, compared with its paralogue BdbC, BdbB was less important for the folding of PhoA (15). These observations prompted us to investigate whether BdbA, BdbB, and BdbC have a role in the production of functional sublancin 168 in particular because this lantibiotic contains two disulfide bonds. The present results show that BdbB and BdbC are involved in the production of active sublancin 168, whereas BdbA is not required. The finding that thiol-disulfide oxidoreductases are required for the synthesis of a peptide antibiotic has never been reported.


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the lantibiotic sublancin 168 as proposed by Paik et al. (9). C, carboxyl terminus; N, amino terminus; S-S, disulfide bond; L, lanthionine bridge.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmids, Bacterial Strains, and Growth Conditions-- Table I lists the plasmids and strains used. TY medium contained Bacto tryptone (1%), Bacto yeast extract (0.5%), and NaCl (0.5%). Antibiotics were used in the following concentrations: ampicillin, 100 µg/ml; chloramphenicol, 5 µg/ml; erythromycin, 2 µg/ml; and kanamycin, 10 µg/ml. Xylose was used at 1% (w/v) concentrations.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Plasmids and bacterial strains

DNA Techniques-- Procedures for DNA purification, restriction, ligation, agarose gel electrophoresis, and transformation of competent E. coli DH5alpha cells were carried out as described by Sambrook et al. (18). Enzymes were from Invitrogen. B. subtilis was transformed as described by Kunst and Rapoport (19). The nucleotide sequences of primers (5'-3') used for PCR are listed below; nucleotides identical to genomic template DNA are printed in capital letters, restriction sites used for cloning are underlined, and nucleotides used for PCR-mediated coupling are in bold.


View larger version (5K):
[in this window]
[in a new window]
 
Fig. 2.   Schematic representation of the sublancin 168 operon. Relative locations of the sun genes for sublancin 168 (sunA) and sublancin 168 transport (sunT), the genes specifying the thiol-disulfide oxidoreductases bdbA and bdbB, and the gene of unknown function, yolJ, are indicated. The distances between the genes are: sunA-sunT, 60 nucleotides; sunT-bdbA, 4 nucleotides overlap; bdbA-yolJ, 2 nucleotides; yolJ-bdbB, 1 nucleotide overlaps.

To construct B. subtilis Delta bdbA, splicing by overlap extension (20) was used. Two fragments flanking the bdbA gene were amplified and ligated into the chromosomal integration and excision plasmid pORI280 (21) after PCR-mediated coupling or ligation. The upstream fragment bdbAfr of 811 nucleotides was amplified using the primers bdbAfr1 (GCA ATC AGA TCT TCA GCA GGC AC) and bdbAfr2 (gtt tca tac tag tta gct aat taa tca TAT AGA ATA CTC CTT ATT TTC CGA GTA GCT CG). The downstream fragment bdbAbk of 1034 nucleotides was amplified with the primers bdbAbk1 (gta ttc tat atg att aat tag cta act agt ATG AAA CTG AGT GAT ATT TAT TTG G) and bdbAbk2 (CAA AAT TGC AGA TCT AAA GTA ATC AAC). The resulting plasmid, pORIbdbA, was first inserted into the chromosome of B. subtilis 168 by a Campbell-type integration. Upon growth in the absence of erythromycin, B. subtilis Delta bdbA was obtained due to the spontaneous excision of the plasmid from the chromosome together with the bdbA gene. Correct integration and excision was verified by Southern hybridization. Note that the bdbA deletion is designed in such a way that the sunT gene remains intact despite the fact that these genes overlap with four nucleotides.

To construct B. subtilis Delta bdbAs+, the carboxyl-terminal part of the sunT gene was amplified with the oligonucleotides sunTrec1 (cgc aca agc tTG TAG CAA AGG CAG TTA TTA GC) and sunTrec2 (CAA TCC gga tcc TCA TAT AGA ATA CTC CTT ATT TTC CG) and ligated into pMutin2 to construct the plasmid pMsunTrec. pMsunTrec was integrated into the chromosome of B. subtilis at the sunT locus by a Campbell-type integration (single crossover) resulting in B. subtilis Delta bdbAs+.

To construct B. subtilis bdbB-XbdbB, the bdbB gene was amplified using the primers yolK1 (CTC CAC tcT Aga GAA CAC GTC CTG AAA GGA ATT GAA GTA TG) and yolKm2 (cgg att acc gga tcc tca gtt cag gtc ctc ctc gct gat aag ttt ttg ttc ATT ATA TAC ATG TTG ATT TTG TTT T). The amplified fragment was ligated into plasmid pX downstream of the xylA promoter. This vector was integrated into the amyE locus of B. subtilis bdbB by double crossover recombination resulting in the strain B. subtilis bdbB-XbdbB.

To construct B. subtilis bdbC-Km,1 first a pUC18 construct containing the bdbC gene was made. Primers yvgU1 (GAA ATt ctA GAG ACA ATA GAA AAA GAG CTG AAA GGG AAG TAA C) and yvgU3 (GCG CCC GGg ATc CGC GGG CGC TTT TTT TGT TAT TCA GAT TTT TCG CCT TTC AGC AGG CAC) were used to amplify the bdbC gene. This fragment was ligated into the multiple cloning site of pUC18 resulting in pUC18bdbC. The NsiI site within the bdbC gene was then used to insert a KmR marker that was isolated from pKM1 (laboratory collection; Jan Kiel) using HincII. In this way pUC18bdbCKm was obtained, and this plasmid was subsequently used to transform B. subtilis 168. A double crossover event then led to B. subtilis bdbC-Km in which the bdbC gene is disrupted by the KmR cassette. Correct integration was verified using Southern hybridization. To construct the double mutant B. subtilis bdbB bdbC-Km, the B. subtilis bdbB strain was transformed with chromosomal DNA of B. subtilis bdbC-Km.

Sublancin 168 Activity Assay-- A halo assay was performed on plates with B. subtilis Delta SPbeta as indicator strain. This strain was constructed using the sequences with the NCBI accession numbers M81760 and M81762 as described by Lazarevic et al. (22). SPbeta -cured B. subtilis strains were previously shown to be sensitive to a bacteriocin (betacin) specified by this prophage (23). Sequencing of the SPbeta region of the B. subtilis 168 chromosome indicated that this bacteriocin is specified by a gene (yolG; Ref. 22), which is now known as the gene for sublancin 168 (sunA). Thus, the SPbeta -cured strain lacks the sunA gene and the as yet unidentified sublancin 168 resistance gene(s). The indicator strain and the mutant strains were grown overnight on TY with the appropriate antibiotic(s). The overnight culture of the indicator strain was then diluted 100-fold in TY, and 100 µl was subsequently plated. After drying the plate, 1-µl aliquots of the overnight cultures of the relevant mutant strains were spotted, and the plates were incubated overnight. The next day plates were analyzed for halo formation. In this assay, the presence of antibiotics in the overnight cultures did not result in halo formation. Importantly variations in the halo size of different colonies of the same strain were insignificant, in particular when these colonies were present on one plate.

Delayed Extraction-Matrix-assisted Laser Desorption Ionization-Time of Flight Mass Spectra (DE-MALDI-TOFMS)-- DE-MALDI-TOFMS were recorded on a Voyager-RP-DE instrument (PerSeptive Biosystems) using a 337 nm nitrogen laser for desorption and ionization. All experiments were carried out with the linear positive ion mode. The total acceleration voltage was 25 kV; 23.6 kV was used on the first grid. The delay time was 250 ns. 1-ml aliquots of culture supernatants and media were extracted with 200 µl of 1-butanol. 150 µl of the butanolic phase was dried in a Speed-Vac evaporator, and extracted peptides were dissolved in 20 µl of solvent A (0.1% trifluoroacetic acid, 20% acetonitrile in water (v/v)) and adsorbed to 1 µl of POROS 50 R2 (PerSeptive) beads prepared as a microcolumn as described by Kussmann et al. (24). After washing with 20 µl of solvent A, the peptides were eluted with 4 µl of a mixture of 70% acetonitrile, 0.1% trifluoroacetic acid in water (v/v). Sample preparation for MALDI was performed with the solution phase nitrocellulose method described by Landry et al. (25). Between 100 and 250 single scans were accumulated for each mass spectrum.

Sequence Similarity Searches and Prediction of Transmembrane Regions-- Similarity searches were performed with the standard protein-protein BLAST algorithm (www.ncbi.nlm.nih.gov/BLAST/) at NCBI (26) using Swiss-Prot as the data base. Transmembrane segments in SunT were predicted using the TMHMM algorithm version 2.0 (www.cbs.dtu.dk/services/TMHMM-2.0/) from the Center for Biological Sequence Analysis (CBS) (27).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SunT Is Required for Sublancin 168 Production-- As a first approach to characterize the factors involved in the production of sublancin 168, the production of this lantibiotic by a sunT mutant strain was tested. It has to be noted that the sunT strain contains a pMutin2 disruption in the 3' end of sunT, placing the downstream bdbA, yolJ, and bdbB genes under the control of the isopropyl-1-thio-beta -D-galactopyranoside-inducible Pspac promoter (Fig. 3). Aliquots of an overnight culture of B. subtilis sunT were spotted on a plate with the sublancin 168-sensitive indicator strain B. subtilis Delta SPbeta . It was found that B. subtilis sunT completely lacked sublancin 168 activity (Fig. 4) also after induction of bdbA, yolJ, and bdbB transcription by the addition of isopropyl-1-thio-beta -D-galactopyranoside (data not shown). The latter observation shows that the lack of sublancin 168 production is not caused by a polar effect on the transcription of the genes located downstream of sunT. Taken together these results demonstrate that SunT is essential for the production of active sublancin 168. In what follows, this conclusion is corroborated by mass spectrometry.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Schematic representation of the relative locations of sunT and bdbA in B. subtilis 168 (top) and B. subtilis sunT (bottom). The Campbell-type integration (single crossover) of pMutin2 leads to the disruption of the 3' end of the sunT gene. Simultaneously the bdbA gene is placed under the transcriptional control of the Pspac promoter. The relative locations of the overlapping start (ATG) and stop (TGA) codons of bdbA and sunT, respectively, are marked. The 3' (sunT') and 5' ('sunT) truncated copies of sunT are indicated.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 4.   Sublancin 168 production in B. subtilis 168 and a sunT mutant. From a 100-fold-diluted overnight culture of the B. subtilis Delta SPbeta indicator strain, 100 µl was plated. After drying of the plate, 1-µl aliquots of overnight cultures of the strains to be tested for sublancin 168 production were spotted, and subsequently the plates were incubated overnight at 37 °C. Sublancin 168 activity is visualized by halo formation.

BdbB Has a Major Role in Sublancin 168 Production-- To investigate whether BdbB is involved in the production of sublancin 168, the halo assay with the Delta SPbeta indicator strain was performed as described above. Indeed, B. subtilis bdbB showed a significantly decreased cell killing activity compared with the parental strain 168, indicating that BdbB is involved in the production of sublancin 168 (Fig. 5). The effect of the bdbB mutation was particularly evident when the cells were grown in the presence of 1% xylose, which is in accord with the observation that xylose affects sublancin 168 production or activity already in the parental strain (Fig. 5, compare the halo size of B. subtilis 168 in the presence and absence of xylose). To determine whether the decreased sublancin 168 activity in B. subtilis bdbB was a direct consequence of the disruption of bdbB, we constructed B. subtilis bdbB-XbdbB, in which the bdbB gene is ectopically expressed from a xylose-inducible promoter. As shown in Fig. 5, the ectopically expressed bdbB gene fully restored the production of active sublancin 168 in the presence of xylose. Thus, BdbB is important but not essential for the production of sublancin 168. 


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 5.   Sublancin 168 production in B. subtilis 168, B. subtilis bdbB, and B. subtilis bdbB-XbdbB. In the latter strain, the ectopic expression of the bdbB gene is controlled by a xylose-inducible promoter. TY plates used in the lower panels were supplemented with 1% xylose. Sublancin 168 production was tested as described in Fig. 4.

BdbC Can Partly Replace BdbB-- The residual activity of sublancin 168 upon disruption of the bdbB gene suggested that another protein was at least partly able to fulfill the role of BdbB. Especially BdbC was a likely candidate because of its high degree of sequence similarity with BdbB (15). Therefore, the possible effect of a bdbC disruption on sublancin production was tested. In contrast to the bdbB mutant, the bdbC mutant produced sublancin 168 at levels that were comparable to those produced by the parental strain (Fig. 6). However, the strain with the bdbB and bdbC genes both disrupted did not display any sublancin 168 activity. This leads to the conclusion that BdbC is not required for production of sublancin 168 when BdbB is present. Nevertheless, BdbC can partly replace BdbB in the absence of the latter.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Sublancin 168 production in B. subtilis 168 and bdbB, bdbC single and double mutant strains. Sublancin 168 production was tested as described in Fig. 4.

BdbA Is Not Required for Sublancin 168 Production-- To investigate the role of BdbA in sublancin 168 production a strain with a clean bdbA deletion was constructed and subsequently tested for sublancin 168 production. This strain did not show any sublancin 168 activity (Fig. 7). However, also when this strain was provided with a bdbA gene that was ectopically expressed from a xylose-inducible promoter, sublancin 168 production was not restored (data not shown). This indicated that bdbA, unlike sunT, is not essential for this process. As shown in Fig. 3, the sunT and bdbA genes are partially overlapping. Thus, the 3' end of the sunT gene might have been damaged during the construction of the clean bdbA deletion strain. Alternatively the deletion of bdbA might interfere with the expression of its downstream genes resulting in reduced levels of active sublancin 168. Therefore, a pMutin2-based integration plasmid containing the 3' end of sunT was constructed. Upon a Campbell-type integration of this plasmid (pMsunTrec), the 3' end of sunT was replaced with the experimentally verified correct sequence. Simultaneously the downstream genes of bdbA were placed under the control of the Pspac promoter. Subsequently we determined whether sublancin 168 activity in the resulting strain Delta bdbAs+ was restored. This was indeed the case as depicted in Fig. 7. The observed sublancin 168 production by this strain, which lacks bdbA, implies that BdbA is dispensable for the production of this lantibiotic.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7.   Sublancin 168 production in B. subtilis Delta bdbA and B. subtilis Delta bdbAs+. Sublancin 168 production was tested as described in Fig. 4.

Subtilosin Production Is Not Affected in bdb Mutants-- In addition to sublancin 168, another bacteriocin of B. subtilis 168 is known for which the presence of a disulfide bond has been proposed initially: subtilosin (28). Subtilosin (29) is composed of 35 amino acids, including three cysteines. Despite the presence of these cysteines, a recent structural analysis of subtilosin by two-dimensional 1H NMR provided no evidence for disulfide bond formation in this bacteriocin (30). To investigate whether the Bdb proteins might, nevertheless, be involved in the synthesis of subtilosin, DE-MALDI-TOF mass spectrometric analyses were performed. Notably this allowed the parallel monitoring of the presence of both subtilosin and sublancin 168 in supernatants of bdb mutant strains. As shown in Fig. 8, subtilosin was identified by its proton-adduct at m/z 3403.3 (average mass; Ref. 30). The presence of sublancin 168 is indicated by a signal at m/z 3881.2 (average mass), which is in good accordance with m/z 3877.8 observed for purified sublancin (Ref. 9; data not shown). The data demonstrate that subtilosin production is not affected in the bdb mutant. Furthermore, the mass spectrometry results concerning sublancin 168 are in accord with the results from the halo assays. Interestingly supplementation of the medium with xylose leads to the appearance of additional signals with appreciably higher masses (+132 and +264 Da) than observed in medium without xylose. This observation can be interpreted with a covalent modification of subtilosin and sublancin 168, suggesting that both bacteriocins are modified under these conditions. In conclusion, the present observations show that SunT and BdbB are major determinants for the production of sublancin 168, whereas the production of subtilosin does not depend on these proteins.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 8.   Mass spectrometric analysis of subtilosin and sublancin 168 production in different B. subtilis strains. The peak cluster at m/z 3400 accounts for the proton-adduct [M + H]+ (m/z 3403.3, average mass) and alkali-adducts of subtilosin (30). The signal observed at m/z 3881.2 is in accordance with the proton adduct of sublancin 168 (average mass).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this report we show for the first time that the presence of at least one thiol-disulfide oxidoreductase, BdbB or BdbC, is required for the production of active sublancin 168. Notably BdbB is of major importance for this process, whereas the involvement of BdbC is only evident in the absence of BdbB. Whether BdbB and BdbC are directly or indirectly involved in sublancin 168 production has yet to be determined. The presence of two disulfide bonds in this lantibiotic makes it conceivable that BdbB and BdbC are directly involved in its folding. However, alternative indirect effects on sublancin 168 folding or maturation cannot be excluded. For example, it is conceivable that BdbB and BdbC act on SunT because this protein contains 10 cysteine residues. SunT belongs to a large family of ATP-binding cassette transporters involved in the processing and export of lantibiotics and other bacteriocins (31). Consistently our present findings show that SunT is required for the production of sublancin 168. Although most ATP-binding cassette transporters appear to contain six transmembrane segments, the bacteriocin transporters are generally characterized by four transmembrane domains (32). In addition, these transporters have a carboxyl-terminal ATP-binding site (33), which is located in the cytoplasm. Specifically SunT shows a high level of sequence similarity to MesD of Leuconostoc mesenteroides (34) and LcnC of Lactococcus lactis (35), the transporters for mesentericin Y105 and lactococcin A, respectively. For LcnC a detailed topology analysis was performed by Franke et al. (36) indicating that this protein has four transmembrane segments. Computer-assisted predictions suggest that SunT, like LcnC, contains four transmembrane sequences, an amino-terminal cytoplasmic peptidase domain (36), and one carboxyl-terminal ATP-binding domain. A fifth hydrophobic domain, which is conserved in LcnC, is probably not spanning the membrane as this would localize the ATP-binding domain at the extracytoplasmic side of the membrane (Fig. 9). Importantly all 10 cysteine residues of SunT have a predicted cytoplasmic localization, which makes them unlikely substrates for BdbB or BdbC, the catalytic domains of which are localized at the extracytoplasmic side of the membrane (15). Consequently an indirect influence of BdbB or BdbC via SunT on sublancin 168 appears to be unlikely.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 9.   Predicted membrane topology of SunT and comparison with the model proposed by Franke et al. (36) for the structurally related LcnC protein. Stars (*) indicate the relative location of the 10 cysteines in SunT. I-VI, hydrophobic domains I-VI; N, amino terminus; C, carboxyl terminus.

Apart from the fact that the SPbeta prophage is required for immunity against sublancin 168, it is presently not known how this immunity is acquired. In general, two distinct systems for immunity against bacteriocins have been described. The first makes use of dedicated "immunity" proteins, small proteins that are weakly associated with the outer surface of the cytoplasmic membrane thereby preventing pore formation (11, 37, 38). The second is constituted of ATP-binding cassette transporters (39-41). In this light, SunT could represent a sublancin 168 immunity system that actively prevents the accumulation of this lantibiotic in the membrane (22). However, our preliminary data show that the sunT mutant used in the present studies is resistant against sublancin 168, which suggests that SunT is not involved. Likewise, BdbA, BdbB, and BdbC are not required for immunity (data not shown).

Although the bdbA gene partly overlaps with the upstream sunT gene, the deletion of this gene in the Delta bdbAS+ strain did not affect the production of active sublancin 168. This is remarkable because BdbA is the equivalent of Bdb of B. brevis, which can replace the major oxidase DsbA of E. coli (16). The fact that BdbA is dispensable for sublancin production does not exclude its possible involvement in this process. For example, another as yet unidentified thiol-disulfide oxidoreductase might complement for the absence of BdbA, similar to what we have shown for BdbC. One of the candidates could be BdbD, which cooperates with BdbC in competence development (42). Both proteins, which are encoded by the bicistronic bdbDC operon, are required for the folding of ComGC most likely because this component of the DNA uptake machinery contains an intramolecular disulfide bond, which is essential for its role in competence (43).

The fact that subtilosin production is not affected in the mutants studied is fully consistent with the recently published structure of this peptide antibiotic (30). According to this model, subtilosin has three inter-residue bridges in which its cysteine residues are involved. Two cysteines are linked with phenylalanine residues, and one is linked with a threonine. This raises the intriguing question of how subtilosin molecules escape from disulfide bond formation during their export in contrast to sublancin 168 molecules.

Strikingly, both for subtilosin and sublancin 168, molecule species were observed with increased molecular mass when B. subtilis bdbB-XbdbB was grown in the presence of 1% xylose. This unprecedented finding shows that subtilosin as well as sublancin 168 can undergo growth medium-dependent modifications. Based on the observed mass increases, it is possible that subtilosin has one xylose adduct (+132 Da), whereas sublancin 168 has either one (+132 Da) or two (+264 Da) of these adducts. Notably Paik et al. (9) have previously reported a modification of sublancin 168 that increases its mass with 164.48 Da. The precise nature of these modifications and their effect on bactericidal activity remain to be elucidated.

In conclusion, the present observations show for the first time an involvement of thiol-disulfide oxidoreductases in the production of a peptide antibiotic. Furthermore, our results reveal an important function of the BdbB and BdbC proteins in the B. subtilis cell. Thus far the BdbB protein was only known to be involved in the folding of the heterologous secretory protein PhoA, whereas BdbC was shown to be required for competence development in addition to the secretion of the heterologous protein PhoA (15, 42). Our ongoing research is focused on the identification of the determinants for the substrate specificities of the thiol-disulfide oxidoreductases of B. subtilis, BdbB and BdbC in particular. For this purpose, it will be of major importance to answer the question of whether BdbB is directly or indirectly involved in the formation of the disulfide bonds of sublancin 168.

    ACKNOWLEDGEMENTS

We thank Jean-Yves Dubois, Karl-Dieter Entian, S. Dusko Ehrlich, Caroline Eschevins, Rob Meima, and members of the Groningen and European Bacillus Secretion Groups for valuable discussions. Furthermore, we greatly acknowledge Michael Karas, University of Frankfurt, for the opportunity to use the PerSeptive MALDI-TOF mass spectrometric equipment.

    FOOTNOTES

* Funding for the project, of which this work is a part, was provided by the Commission of the European Union Projects BIO4-CT98-0250, QLK3-CT-1999-00413, and QLK3-CT-1999-00917.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** Present address: Dept. of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom.

Dagger Dagger To whom correspondence should be addressed. Tel.: 31-50-363-3079; Fax: 31-50-363-3000; E-mail: W.J.Quax@farm.rug.nl.

Published, JBC Papers in Press, February 28, 2002, DOI 10.1074/jbc.M201158200

    ABBREVIATIONS

The abbreviations used are: Km, kanamycin; DE-MALDI-TOFMS, delayed extraction-matrix-assisted laser desorption ionization-time of flight mass spectra.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Tjalsma, H., Bolhuis, A., Jongbloed, J. D., Bron, S., and van Dijl, J. M. (2000) Microbiol. Mol. Biol. Rev. 64, 515-547[Abstract/Free Full Text]
2. Sonenshein, A. L., Hoch, J. A., and Losick, R. (2001) Bacillus subtilis and Its Closest Relatives , 1st Ed. , ASM Press, Washington, D. C.
3. McAuliffe, O., Ross, R. P., and Hill, C. (2001) FEMS Microbiol. Rev. 25, 285-308[CrossRef][Medline] [Order article via Infotrieve]
4. Sahl, H. G., and Bierbaum, G. (1998) Annu. Rev. Microbiol. 52, 41-79[CrossRef][Medline] [Order article via Infotrieve]
5. Jack, R. W., Tagg, J. R., and Ray, B. (1995) Microbiol. Rev. 59, 171-200[Abstract/Free Full Text]
6. Guder, A., Wiedemann, I., and Sahl, H. G. (2000) Biopolymers 55, 62-73[CrossRef][Medline] [Order article via Infotrieve]
7. Chung, Y. J., Steen, M. T., and Hansen, J. N. (1992) J. Bacteriol. 174, 1417-1422[Abstract/Free Full Text]
8. Kiesau, P., Eikmanns, U., Gutowski-Eckel, Z., Weber, S., Hammelmann, M., and Entian, K.-D. (1997) J. Bacteriol. 179, 1475-1481[Abstract/Free Full Text]
9. Paik, S. H., Chakicherla, A., and Hansen, J. N. (1998) J. Biol. Chem. 273, 23134-23142[Abstract/Free Full Text]
10. Stein, T., Borchert, S., Conrad, B., Feesche, J., Hofemeister, B., Hofemeister, J., and Entian, K.-D. (2002) J. Bacteriol. 184, 1703-1711[Abstract/Free Full Text]
11. Saris, P. E., Immonen, T., Reis, M., and Sahl, H. G. (1996) Antonie Leeuwenhoek 69, 151-159[CrossRef][Medline] [Order article via Infotrieve]
12. van der Meer, J. R., Rollema, H. S., Siezen, R. J., Beerthuyzen, M. M., Kuipers, O. P., and de Vos, W. M. (1994) J. Biol. Chem. 269, 3555-3562[Abstract/Free Full Text]
13. Chakicherla, A., and Hansen, J. N. (1995) J. Biol. Chem. 270, 23533-23539[Abstract/Free Full Text]
14. Ritz, D., and Beckwith, J. (2001) Annu. Rev. Microbiol. 55, 21-48[CrossRef][Medline] [Order article via Infotrieve]
15. Bolhuis, A., Venema, G., Quax, W. J., Bron, S., and van Dijl, J. M. (1999) J. Biol. Chem. 274, 24531-24538[Abstract/Free Full Text]
16. Ishihara, T., Tomita, H., Hasegawa, Y., Tsukagoshi, N., Yamagata, H., and Udaka, S. (1995) J. Bacteriol. 177, 745-749[Abstract/Free Full Text]
17. Bardwell, J. C., Lee, J. O., Jander, G., Martin, N., Belin, D., and Beckwith, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1038-1042[Abstract/Free Full Text]
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratories, Cold Spring Harbor, NY
19. Kunst, F., and Rapoport, G. (1995) J. Bacteriol. 177, 2403-2407[Abstract/Free Full Text]
20. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 61-68[CrossRef][Medline] [Order article via Infotrieve]
21. Leenhouts, K., Buist, G., Bolhuis, A., ten Berge, A., Kiel, J., Mierau, I., Dabrowska, M., Venema, G., and Kok, J. (1996) Mol. Gen. Genet. 253, 217-224[CrossRef][Medline] [Order article via Infotrieve]
22. Lazarevic, V., Dusterhoft, A., Soldo, B., Hilbert, H., Mauel, C., and Karamata, D. (1999) Microbiology 145, 1055-1067[Abstract]
23. Hemphill, H. E., Gage, I., Zahler, S. A., and Korman, R. Z. (1980) Can. J. Microbiol. 26, 1328-1333[Medline] [Order article via Infotrieve]
24. Kussmann, M., Nordhoff, E., Rahbek-Nielsen, H., Haebel, S., Rossel-Larsen, M., Jakobsen, L., Gobom, J., Mirgorodskaya, E., Kroll-Kristensen, A., Palm, L., and Roepstorff, P. (1997) J. Mass Spectrom. 32, 593-601[CrossRef]
25. Landry, F., Lombardo, C. R., and Smith, J. W. (2000) Anal. Biochem. 279, 1-8[CrossRef][Medline] [Order article via Infotrieve]
26. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
27. Moller, S., Croning, M. D., and Apweiler, R. (2001) Bioinformatics 17, 646-653[Abstract/Free Full Text]
28. Zheng, G., Hehn, R., and Zuber, P. (2000) J. Bacteriol. 182, 3266-3273[Abstract/Free Full Text]
29. Babasaki, K., Takao, T., Shimonishi, Y., and Kurahashi, K. (1985) J. Biochem. (Tokyo) 98, 585-603[Abstract/Free Full Text]
30. Marx, R., Stein, T., Entian, K.-D., and Glaser, S. J. (2001) J. Protein Chem. 20, 501-506[CrossRef][Medline] [Order article via Infotrieve]
31. Higgins, C. F. (1992) Annu. Rev. Cell Biol. 8, 67-113[CrossRef][Medline] [Order article via Infotrieve]
32. Fath, M. J., and Kolter, R. (1993) Microbiol. Rev. 57, 995-1017[Abstract/Free Full Text]
33. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951[Medline] [Order article via Infotrieve]
34. Fremaux, C., Hechard, Y., and Cenatiempo, Y. (1995) Microbiology 141, 1637-1645[Abstract]
35. Stoddard, G. W., Petzel, J. P., van Belkum, M. J., Kok, J., and McKay, L. L. (1992) Appl. Environ. Microbiol. 58, 1952-1961[Abstract/Free Full Text]
36. Franke, C. M., Tiemersma, J., Venema, G., and Kok, J. (1999) J. Biol. Chem. 274, 8484-8490[Abstract/Free Full Text]
37. Siegers, K., and Entian, K.-D. (1995) Appl. Environ. Microbiol. 61, 1082-1089[Abstract]
38. Kuipers, O. P., Beerthuyzen, M. M., Siezen, R. J., and de Vos, W. M. (1993) Eur. J. Biochem. 216, 281-291[Medline] [Order article via Infotrieve]
39. McLaughlin, R. E., Ferretti, J. J., and Hynes, W. L. (1999) FEMS Microbiol. Lett. 175, 171-177[CrossRef][Medline] [Order article via Infotrieve]
40. Peschel, A., and Gotz, F. (1996) J. Bacteriol. 178, 531-536[Abstract/Free Full Text]
41. Klein, C., and Entian, K.-D. (1994) Appl. Environ. Microbiol. 60, 2793-2801[Abstract/Free Full Text]
42. Meima, R., Eschevins, C., Fillinger, S., Bolhuis, A., Hamoen, L. W., Dorenbos, R., Quax, W. J., van Dijl, J. M., Provvedi, R., Chen, I., Dubnau, D., and Bron, S. (2002) J. Biol. Chem. 277, 6994-7001[Abstract/Free Full Text]
43. Chung, Y. S., Breidt, F., and Dubnau, D. (1998) Mol. Microbiol. 29, 905-913[CrossRef][Medline] [Order article via Infotrieve]
44. Norrander, J., Kempe, T., and Messing, J. (1983) Gene (Amst.) 26, 101-106[CrossRef][Medline] [Order article via Infotrieve]
45. Vagner, V., Dervyn, E., and Ehrlich, S. D. (1998) Microbiology 144, 3097-3104[Abstract]
46. Kim, L., Mogk, A., and Schumann, W. (1996) Gene (Amst.) 181, 71-76[CrossRef][Medline] [Order article via Infotrieve]
47. Kunst, F., Ogasawara, N., Moszer, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., Bessieres, P., Bolotin, A., Borchert, S., Borriss, R., Boursier, L., Brans, A., Braun, M., Brignell, S. C., Bron, S., Brouillet, S., Bruschi, C. V., Caldwell, B., Capuano, V., Carter, N. M., Choi, S. K., Codani, J. J., Connerton, I. F., and Danchin, A. (1997) Nature 390, 249-256[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Dutton, D. Boyd, M. Berkmen, and J. Beckwith
Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation
PNAS, August 19, 2008; 105(33): 11933 - 11938.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
L. Fontaine and P. Hols
The Inhibitory Spectrum of Thermophilin 9 from Streptococcus thermophilus LMD-9 Depends on the Production of Multiple Peptides and the Activity of BlpGSt, a Thiol-Disulfide Oxidase
Appl. Envir. Microbiol., February 15, 2008; 74(4): 1102 - 1110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Heras, M. Kurz, R. Jarrott, S. R. Shouldice, P. Frei, G. Robin, M. Cemazar, L. Thony-Meyer, R. Glockshuber, and J. L. Martin
Staphylococcus aureus DsbA Does Not Have a Destabilizing Disulfide: A NEW PARADIGM FOR BACTERIAL OXIDATIVE FOLDING
J. Biol. Chem., February 15, 2008; 283(7): 4261 - 4271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lewin, A. Crow, A. Oubrie, and N. E. Le Brun
Molecular Basis for Specificity of the Extracytoplasmic Thioredoxin ResA
J. Biol. Chem., November 17, 2006; 281(46): 35467 - 35477.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. McClerren, L. E. Cooper, C. Quan, P. M. Thomas, N. L. Kelleher, and W. A. van der Donk
Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic
PNAS, November 14, 2006; 103(46): 17243 - 17248.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
E. Darmon, R. Dorenbos, J. Meens, R. Freudl, H. Antelmann, M. Hecker, O. P. Kuipers, S. Bron, W. J. Quax, J.-Y. F. Dubois, et al.
A Disulfide Bond-Containing Alkaline Phosphatase Triggers a BdbC-Dependent Secretion Stress Response in Bacillus subtilis.
Appl. Envir. Microbiol., November 1, 2006; 72(11): 6876 - 6885.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. Albano, W. K. Smits, L. T. Y. Ho, B. Kraigher, I. Mandic-Mulec, O. P. Kuipers, and D. Dubnau
The Rok Protein of Bacillus subtilis Represses Genes for Cell Surface and Extracellular Functions
J. Bacteriol., March 15, 2005; 187(6): 2010 - 2019.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
L. S. Erlendsson, M. Moller, and L. Hederstedt
Bacillus subtilis StoA Is a Thiol-Disulfide Oxidoreductase Important for Spore Cortex Synthesis
J. Bacteriol., September 15, 2004; 186(18): 6230 - 6238.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Tjalsma, H. Antelmann, J. D.H. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J.-Y. F. Dubois, H. Westers, G. Zanen, W. J. Quax, et al.
Proteomics of Protein Secretion by Bacillus subtilis: Separating the "Secrets" of the Secretome
Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 207 - 233.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
H. Westers, R. Dorenbos, J. M. van Dijl, J. Kabel, T. Flanagan, K. M. Devine, F. Jude, S. J. Seror, A. C. Beekman, E. Darmon, et al.
Genome Engineering Reveals Large Dispensable Regions in Bacillus subtilis
Mol. Biol. Evol., December 1, 2003; 20(12): 2076 - 2090.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available